Skip to main content

Table 3 Neoadjuvant therapy

From: Potential risk of residual cancer cells in the surgical treatment of initially unresectable pancreatic carcinoma after chemoradiotherapy

Chemo(radio)therapy Regimen n Period of therapy (month)
Chemotherapy (IV) GEM + S-1 10 8.5 (5–32)
  GEM 1 11
Chemotherapy (TA) GEM + 5-FU 3 7/34/44
Chemoradiotherapy GEM + S-1 2 7/16
  GEM + 5-FU 1 8
  GEM 1 32
    9 (5–44)
  1. GEM gemcitabine, 5-FU 5-fluorouracil